Cargando…

New Immunotherapy Strategies in Breast Cancer

Breast cancer is the most commonly diagnosed cancer among women. Therapeutic treatments for breast cancer generally include surgery, chemotherapy, radiotherapy, endocrinotherapy and molecular targeted therapy. With the development of molecular biology, immunology and pharmacogenomics, immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Lin-Yu, Tang, Jie, Zhang, Cong-Min, Zeng, Wen-Jing, Yan, Han, Li, Mu-Peng, Chen, Xiao-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295319/ https://www.ncbi.nlm.nih.gov/pubmed/28085094 http://dx.doi.org/10.3390/ijerph14010068

Ejemplares similares

Immunotherapy Strategies Against Multiple Myeloma
por: Ma, Jing, et al.
Publicado: (2017)

Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy
por: Yang, Pengxiang, et al.
Publicado: (2021)

Case Report: Response to Immunotherapy and Anti-Androgen Therapy in Male Occult Triple-Negative Breast Cancer
por: Wang, Xin-Hua, et al.
Publicado: (2022)

Nanoengineered targeting strategy for cancer immunotherapy
por: Yin, Wei-min, et al.
Publicado: (2020)

The Application of and Strategy for Gold Nanoparticles in Cancer Immunotherapy
por: He, Jia-shuai, et al.
Publicado: (2021)

Immunotherapy in Breast Cancer: the New Frontier
por: Hu, Zishuo I., et al.
Publicado: (2018)

Combination Strategies of Checkpoint Immunotherapy in Metastatic Breast Cancer
por: Liu, Zhi Bing, et al.
Publicado: (2020)

Immunotherapy in breast cancer: an overview of current strategies and perspectives
por: Debien, Véronique, et al.
Publicado: (2023)

Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)

Cytokine-induced killer cells: A novel immunotherapy strategy for leukemia
por: YANG, XIN-YU, et al.
Publicado: (2015)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Progress: Targeted Therapy, Immunotherapy, and New Chemotherapy Strategies in Advanced Triple-Negative Breast Cancer
por: Shi, Jinhong, et al.
Publicado: (2020)

Cancer immunotherapy strategies that target the cGAS-STING pathway
por: Tian, Zhuoying, et al.
Publicado: (2022)

Tumor-associated macrophage-related strategies for glioma immunotherapy
por: Tang, Fansong, et al.
Publicado: (2023)

New strategies for cancer immunotherapy: targeting regulatory T cells
por: Finotello, Francesca, et al.
Publicado: (2017)

Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients
por: Yu, Honghao, et al.
Publicado: (2022)

Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy
por: Lin, Liangbin, et al.
Publicado: (2019)

The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance
por: Retecki, Kuba, et al.
Publicado: (2021)

Safety Strategies of Genetically Engineered T Cells in Cancer Immunotherapy
por: Ren, Yan-Bei, et al.
Publicado: (2018)

Immunotherapy of hepatocellular carcinoma: recent progress and new strategy
por: Li, Jiarui, et al.
Publicado: (2023)

Post translational modification-assisted cancer immunotherapy for effective breast cancer treatment
por: Theivendran, Shevanuja, et al.
Publicado: (2020)

Immunotherapy for Triple-Negative Breast Cancer: Combination Strategies to Improve Outcome
por: Li, Liying, et al.
Publicado: (2023)

Immunotherapy for the Treatment of Breast Cancer: Emerging New Data
por: Mina, Lida A, et al.
Publicado: (2019)

A new strategy for the treatment of heavily pretreated metastatic breast cancer: A case report and review of the literature
por: Ge, Ting-Ting, et al.
Publicado: (2023)

Immunotherapy-related toxicity in lung cancer: clinical characteristics and managing strategy
por: Luo, Wen-Xin, et al.
Publicado: (2021)

Iodine-Rich Nanoadjuvants for CT Imaging–Guided Photodynamic Immunotherapy of Breast Cancer
por: Xin, Xiaoyan, et al.
Publicado: (2022)

Mechanism and strategies of immunotherapy resistance in colorectal cancer
por: Shan, Jiqi, et al.
Publicado: (2022)

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer
por: Ji, Peng, et al.
Publicado: (2022)

HOW TO HARNESS NEW IMMUNOTHERAPIES WITH COMBINATION STRATEGIES?
por: Einsele, H.
Publicado: (2023)

Nanomaterials in tumor immunotherapy: new strategies and challenges
por: Zhu, Xudong, et al.
Publicado: (2023)

The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
por: Ding, Lei, et al.
Publicado: (2020)

The Emerging Role of T-Cell Immunoglobulin Mucin-3 in Breast Cancer: A Promising Target For Immunotherapy
por: Cong, Yizi, et al.
Publicado: (2021)

Immunotherapy in breast cancer
por: Bayraktar, Soley, et al.
Publicado: (2019)

Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies
por: Cilibrasi, Chiara, et al.
Publicado: (2021)

Strategies for Bispecific Single Chain Antibody in Cancer Immunotherapy
por: Zhou, Shu-juan, et al.
Publicado: (2017)

Chemokines and chemokine receptors: A new strategy for breast cancer therapy
por: Liu, Hui, et al.
Publicado: (2020)

Ultrasound guided percutaneous microwave ablation of benign breast lesions
por: Yu, Jie, et al.
Publicado: (2017)

Editorial: Using multi-omics to develop new strategies to improve prognosis and immunotherapy outcomes in cancers
por: Cao, Chenxi, et al.
Publicado: (2023)

Stress, coping strategies and expectations among breast cancer survivors in China: a qualitative study
por: Hu, Ruo-Yu, et al.
Publicado: (2021)

Esophageal stenosis after chemotherapy for breast cancer: A case report
por: Ou, Zhen-Fei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0jpeesadfrf788rd3p1dco38mk